United Therapeutics Corp

XMUN:UTH

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UTH's stock price target?

Price Target

576.46 EUR

According to Wall Street analysts, the average 1-year price target for UTH is 576.46 EUR with a low forecast of 450.61 EUR and a high forecast of 659.47 EUR.

What is the Revenue forecast for United Therapeutics Corp?

Projected CAGR

13%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for United Therapeutics Corp?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.

What is the Operating Income forecast for United Therapeutics Corp?

Projected CAGR

14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.

What is the Pre-Tax Income forecast for United Therapeutics Corp?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 8%.

What is the Net Income forecast for United Therapeutics Corp?

Projected CAGR

11%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.